Category: Becker’s ASC Review

8 federal policy updates for physicians to know this month

With a flurry of federal updates coming out of Washington as the Trump administration continues to take shape, here are eight federal policy updates relevant to ASC leaders and physicians: 

The battle over anesthesia coverage: A timeline

In late 2024, Anthem Blue Cross Blue Shield proposed a policy that would have imposed time limits on anesthesia reimbursements in Missouri, New York and Connecticut. This was met with an intense backlash from the physicians and leaders in healthcare an…

Cardiologists on the move in February

Here are four cardiologists joining new health systems and entering new roles, as reported by Becker’s in February:

5 GI groups expanding services in 1 month 

Here are five gastroenterology groups that expanded services in the last month:

What's next for healthcare private equity?

Here are three recent studies, policy updates and market trends that could affect healthcare private equity groups in the near future:  

Is ASC sustainability in danger?

As more procedures shift to the outpatient setting, many ASCs are feeling the financial squeeze, with rising costs and stagnant reimbursements making it increasingly difficult to maintain healthy margins.

Why patients aren't getting screened for GI cancer

Fear and anxiety may be the key reasons why patients are choosing not to undergo screenings for colorectal cancer. 

5 hospital closures in February 

Here’s five hospitals Becker’s has reported on closing since Feb. 1:

New York state senator introduces bill to ban noncompetes

New York state Sen. Paul Ryan has introduced a bill that expands upon a 2023 proposal to ban most noncompete agreements in the state. 

5 year growth of the 5 biggest ASC companies

The ASC industry has seen significant shifts over the past five years, with ASC giants like United Surgical Partners International nearly doubling its portfolio since 2019.